Neuroprotective properties of adenosine A2A receptor antagonists in animal models of Parkinson's disease

被引:0
|
作者
Wardas, Jadwiga [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, PL-31343 Krakow, Poland
关键词
D O I
10.1016/S1734-1140(11)70670-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1283 / 1283
页数:1
相关论文
共 50 条
  • [21] Novel investigational adenosine A2A receptor antagonists for Parkinson's disease
    Pinna, Annalisa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1619 - 1631
  • [22] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease
    Mori, Akihisa
    Chen, Jiang-Fan
    Uchida, Shinichi
    Durlach, Cecile
    King, Shelby M.
    Jenner, Peter
    MOLECULES, 2022, 27 (07):
  • [23] New therapies for the treatment of Parkinson's disease:: Adenosine A2A receptor antagonists
    Pinna, A
    Wardas, J
    Simola, N
    Morelli, M
    LIFE SCIENCES, 2005, 77 (26) : 3259 - 3267
  • [24] Caffeine, Chocolate and Adenosine A2A Receptor Antagonists in the Treatment of Parkinson's Disease
    Reichmann, Heinz
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2023, 91 (06) : 256 - 261
  • [25] Adenosine A2A receptor inactivation in neuronal elements is neuroprotective in a model of Parkinson's disease
    Schintu, N.
    Carta, A. R.
    Kachroo, A.
    Xu, K.
    Morelli, M.
    Schwarzschild, M. A.
    MOVEMENT DISORDERS, 2009, 24 : S362 - S363
  • [26] Can adenosine A2A receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson's disease?
    Kanda, Tomoyuki
    Jenner, Peter
    PARKINSONISM & RELATED DISORDERS, 2020, 80 : S21 - S27
  • [27] Mode of Action of Adenosine A2A Receptor Antagonists as Symptomatic Treatment for Parkinson's Disease
    Mori, Akihisa
    ADENOSINE RECEPTORS IN NEUROLOGY AND PSYCHIATRY, 2014, 119 : 87 - 116
  • [28] Recent progress in the discovery of adenosine A2A receptor antagonists for the treatment of Parkinson's disease
    Shah, Unmesh
    Hodgson, Robert
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (04) : 466 - 480
  • [29] Adenosine A2A receptor antagonists and Parkinson's disease:: State of the art and future directions
    Simola, N.
    Morelli, M.
    Pinna, A.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (15) : 1475 - 1489
  • [30] Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
    Armentero, Marie Therese
    Pinna, Annalisa
    Ferre, Sergi
    Luis Lanciego, Jose
    Mueller, Christa E.
    Franco, Rafael
    PHARMACOLOGY & THERAPEUTICS, 2011, 132 (03) : 280 - 299